An IkappaBalpha inhibitor causes leukemia cell death through a p38 MAP kinase-dependent, NF-kappaB-independent mechanism. [electronic resource]
Producer: 20010906Description: 6290-6 p. digitalISSN:- 0008-5472
- Activating Transcription Factor 2
- Anti-Infective Agents -- antagonists & inhibitors
- Apoptosis -- drug effects
- Cyclic AMP Response Element-Binding Protein -- metabolism
- DNA-Binding Proteins -- antagonists & inhibitors
- Dose-Response Relationship, Drug
- Enzyme Activation
- Enzyme Inhibitors -- pharmacology
- Humans
- I-kappa B Proteins
- Imidazoles -- pharmacology
- Leukemia, Myeloid -- enzymology
- MAP Kinase Kinase Kinase 1
- Mitogen-Activated Protein Kinases -- antagonists & inhibitors
- NF-KappaB Inhibitor alpha
- NF-kappa B -- physiology
- Necrosis
- Nitriles
- Phosphorylation
- Protein Serine-Threonine Kinases -- antagonists & inhibitors
- Pyridines -- pharmacology
- Sulfones
- Transcription Factors -- metabolism
- Tumor Cells, Cultured -- drug effects
- U937 Cells
- p38 Mitogen-Activated Protein Kinases
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.